read more like I was told
Supplementary material The Supplementary Material for this article can be found online at: References 1 BrayFLaversanneMSungHFerlayJSiegelRLSoerjomataramIet al
For context, NICE guidance on obesity pharmacotherapy including TA875 (semaglutide for weight management) and TA924 (tirzepatide for managing overweight and obesity) provides a useful framework for understanding how future agents might be positioned in the UK
Although the chemistry behind this ingredient may initially sound technical, its significance in skincare lies in the way it connects scientific research with cosmetic formulation
Nat Med 18:18471856 Schwenk RW, Baumeier C, Finan B et al (2015) GLP-1-oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone New Zealand obese (NZO) mice
WHOs endorsement of obesity medications should provide optimism for so many struggling with obesity, as many have felt shame and blame for a chronic condition that does have biological roots